In this patient perspective find out T.J.’s perspective on the potentially practice-changing lung cancer findings presented at the AACR 2018.
Browsing: lung cancer
This world-first-treatment could potentially offer hope to lung cancer patients with previously untreatable lung tumors.
Keep checking back throughout the conference, we will be updating this article with the biggest news headlines from the American Association for Cancer Research (AACR) Annual Meeting 2018 (April 14–18, IL, USA).
Merck has extended its all-important lung-cancer lead, after combination Phase III trial demonstrates that Keytruda extends lung cancer survival.
Discover whether radiotherapy may have a promising role in synergistically enhancing the systemic response to immune checkpoint inhibition in this editorial from Future Oncology.
Recent results from Roche’s Phase III IMpower 150 lung cancer study have demonstrated that atezolizumab, bevacizumab, chemotherapy combination doubles 12-month PFS.
The EU Position Statement on Lung Cancer Screening (EUPS) has presented evidence to address successful implementation of lung cancer screening programs for European countries.
Would you like to find out the key facts about non-small-cell lung cancer? We have…
Three single-nucleotide polymorphisms have been identified as viable candidates as biomarkers for the personalized monitoring and treatment of lung cancers.